The HIV drug raltegravir, which blocks viral integration into the genome, results in a transient increase in episomes, circularized HIV DNA. The findings suggest that persistent HIV replication occurs in people on antiretroviral therapy. Measuring episomes may also offer a new method to study viral persistence and latency and to gauge the effectiveness of antiviral regimens (pages 460–465).
This is a preview of subscription content, log in via an institution to check access.
Kim Caesar
References
El-Sadr, W.M. et al. N. Engl. J. Med. 355, 2283–2296 (2006).
Davey, R.T. Jr. et al. Proc. Natl. Acad. Sci. USA 96, 15109–15114 (1999).
Chun, T.W. et al. Proc. Natl. Acad. Sci. USA 94, 13193–13197 (1997).
Wong, J.K. et al. Science 278, 1291–1295 (1997).
Sedaghat, A.R. et al. PLoS Pathog. 3, e122 (2007).
Cavert, W. et al. Science 276, 960–964 (1997).
Furtado, M.R. et al. N. Engl. J. Med. 340, 1614–1622 (1999).
Havlir, D.V. et al. J. Virol. 77, 11212–11219 (2003).
Buzón, M.J. et al. Nat. Med. 16, 460–465 (2010).
Pauza, C.D. et al. Virology 205, 470–478 (1994).
Riddler, S.A. et al. N. Engl. J. Med. 358, 2095–2106 (2008).
Daar, E. et al. http://retroconference.org/2010/Abstracts/39789.htm (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Schacker, T. New tools to track HIV. Nat Med 16, 373–374 (2010). https://doi.org/10.1038/nm0410-373
Issue Date:
DOI: https://doi.org/10.1038/nm0410-373
- Springer Nature America, Inc.
This article is cited by
-
Eliminating the HIV Reservoir
Current HIV/AIDS Reports (2012)